ArticleNature medicine2023
Author Correction: Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Polatuzumab vedotin-containing regimens as bridge to CART: analysis from the CART-SIE study.Blood advances · 2026Observational
- Throwing the microbiome out with the bathwater.Blood advances · 2025Article
- Review
- CAR T-cell toxicities: from bedside to bench, how novel toxicities inform laboratory investigations.Blood advances · 2024Review
- Microbiome in Cancer Development and Treatment.Microorganisms · 2023Review
- Lymphodepletion - an essential but undervalued part of the chimeric antigen receptor T-cell therapy cycle.Frontiers in immunology · 2023Review
Corrections and comments
- Erratum for
Authors and funding
49 authors.
Melody SmithAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-2702-0381
Anqi Dai *Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Guido Ghilardi *Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Kimberly V AmelsbergCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Sean M DevlinDepartment of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Raymone PajarilloCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
John B SlingerlandAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Silvia BeghiDepartment of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
Pamela S HerreraAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Paul GiardinaAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Annelie ClurmanAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Emmanuel DwomohAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Gabriel ArmijoAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Antonio L C GomesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0003-3790-3724
Eric R LittmannThe Duchossois Family Institute, University of Chicago, Chicago, IL, USA.
Jonas SchluterInstitute for Computational Medicine, New York University Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0002-6214-9367
Emily FontanaMolecular Microbiology Core Facility, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Ying TaurInfectious Disease Service, Department of Medicine, and Immunology Program, Sloan Kettering Institute, New York, NY, USA.ORCID http://orcid.org/0000-0002-6601-8284
Jae H ParkDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-2903-5130
Maria Lia PalombaDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0001-5099-9156
Elizabeth HaltonCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Josel RuizAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Tania JainDivision of Hematologic Malignancies and Bone Marrow Transplantation, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD, USA.ORCID http://orcid.org/0000-0001-6854-773X
Martina PennisiDepartment of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
Aishat Olaide AfuyeAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5751-3283
Miguel-Angel PeralesAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-5910-4571
Craig W FreyerDepartment of Pharmacy, Hospital of the University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-6526-8134
Alfred GarfallCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Shannon GierCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Sunita NastaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Daniel LandsburgCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
James GersonCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Jakub SvobodaCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Justin CrossThe Donald B. and Catherine C. Marron Cancer Metabolism Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Elise A ChongCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0001-8895-1625
Sergio GiraltAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Saar I GillCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Isabelle RiviereCellular Therapeutics Center, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
David L PorterCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Stephen J SchusterCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Michel SadelainCenter for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9031-8025
Noelle FreyCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.
Renier J BrentjensDepartment of Medicine, Weill Cornell Medical College, New York, NY, USA.ORCID http://orcid.org/0000-0002-3364-5388
Carl H JuneCenter for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0003-0241-3557
Eric G PamerThe Duchossois Family Institute, University of Chicago, Chicago, IL, USA.
Jonathan U PeledAdult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-4029-7625
Andrea Facciabene *Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. facciabe@pennmedicine.upenn.edu.ORCID http://orcid.org/0000-0002-9563-297X
Marcel R M van den Brink *Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. vandenbm@mskcc.org.ORCID http://orcid.org/0000-0003-0696-4401
Marco Ruella *Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA, USA. mruella@upenn.edu.ORCID http://orcid.org/0000-0003-4301-5811
Funding
Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Luis J Montaner · 1985 to 2026
$75.9MProject 3: Combinatorial and gene-editing approaches to enhance the efficacy of CAR T cell therapy of multiple myeloma.P01CA214278 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CARL H. JUNE · 2017 to 2026
$26.8MMODULATION OF CD5 SIGNALING TO ENHANCE ADOPTIVE T-CELL THERAPIES FOR CANCERR37CA262362 · NCI · UNIVERSITY OF PENNSYLVANIA · PI Marco Ruella · 2022 to 2026
$2.6MResistance To Targeted Immunotherapies:CART19 as a ParadigmR00CA212302 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RUELLA, MARCO · 2018 to 2020
$608kResistance To Targeted Immunotherapies:CART19 as a ParadigmK99CA212302 · NCI · UNIVERSITY OF PENNSYLVANIA · PI RUELLA, MARCO · 2017 to 2018
$348kNCI NIH HHS K99 CA212302NCI NIH HHS P01 CA214278NCI NIH HHS R00 CA212302NCI NIH HHS R37 CA262362
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.